Paroxetine-d4

Synonyms: 帕罗西汀-d4; BRL29060-d4
Paroxetine-d4 (BRL29060-d4) 是一种氘代标记的 Paroxetine (MS-M41484),而 Paroxetine (BRL29060) 是一种口服有效、可穿透血脑屏障的选择性血清素再摄取抑制剂 (SSRI) 和凋亡 (apoptosis) 诱导剂,可抑制一氧化氮合酶和 CYP2D6,诱导 5-HT1A/1B/1D 自身受体脱敏并下调 5-HT2 受体,同时诱导炎症因子生成,此外它还是弱的去甲肾上腺素 (NE) 摄取抑制剂并具有抗肿瘤活性,可广泛应用于抑郁症、强迫症、惊恐障碍、社交恐惧症、广泛性焦虑障碍、创伤后应激障碍、经前烦躁障碍及潮热等相关疾病的研究。
产品编号: MS-Z99959 CAS No.: 923932-45-0 分子式: C19H16D4FNO3 分子量: 333.39
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

Paroxetine-d4 (BRL29060-d4) 是一种氘代标记的 Paroxetine (MS-M41484),而 Paroxetine (BRL29060) 是一种口服有效、可穿透血脑屏障的选择性血清素再摄取抑制剂 (SSRI) 和凋亡 (apoptosis) 诱导剂,可抑制一氧化氮合酶和 CYP2D6,诱导 5-HT1A/1B/1D 自身受体脱敏并下调 5-HT2 受体,同时诱导炎症因子生成,此外它还是弱的去甲肾上腺素 (NE) 摄取抑制剂并具有抗肿瘤活性,可广泛应用于抑郁症、强迫症、惊恐障碍、社交恐惧症、广泛性焦虑障碍、创伤后应激障碍、经前烦躁障碍及潮热等相关疾病的研究。

生物实验数据

生物活性 Paroxetine-d4 (BRL29060-d4) is a deuterium-labeled Paroxetine (MS-M41484), while Paroxetine (BRL29060) is an orally active, blood-brain barrier-penetrant selective serotonin reuptake inhibitor (SSRI) and apoptosis inducer that inhibits nitric oxide synthase and CYP2D6, induces desensitization of 5-HT1A/1B/1D autoreceptors and downregulates 5-HT2 receptors, induces inflammatory cytokine production, and is also a weak norepinephrine (NE) uptake inhibitor with antitumor activity, making it widely applicable in research on depression, obsessive-compulsive disorder, panic disorder, social phobia, generalized anxiety disorder, post-traumatic stress disorder, premenstrual dysphoric disorder, hot flashes, and related diseases.
IC50 & Target

CYP2D6

 

5-HT2 Receptor

 

体外研究
(In Vitro)

ELISA Assay

Cell Line: Raw264.7 mouse macrophages
Concentration: 10 μM; 20 μM
Incubation Time: 6 h; 24 h
Result: Reduced LPS-induced IL-6 production to ~75% of LPS-only levels at 6 hours with 10 μM.
Reduced LPS-induced IL-6 production to ~50% of LPS-only levels at 6 hours with 20 μM.
Reduced LPS-induced IL-6 production to ~80% of LPS-only levels at 24 hours with 10 μM.
Reduced LPS-induced IL-6 production to ~60% of LPS-only levels at 24 hours with 20 μM.
Increased LPS-induced TNFα production to ~155% of LPS-only levels at 6 hours with 10 μM.
Increased LPS-induced TNFα production to ~195% of LPS-only levels at 6 hours with 20 μM.
Increased LPS-induced TNFα production to ~120% of LPS-only levels at 24 hours with 10 μM.
Increased LPS-induced TNFα production to ~145% of LPS-only levels at 24 hours with 20 μM.

ELISA Assay

Cell Line: Raw264.7 mouse macrophages pretreated with 5-HT2/5-HT7 receptor antagonist LY215840
Concentration: 20 μM
Incubation Time: 24 h
Result: Reduced LPS-induced IL-6 production to ~45% of LPS-only levels.
Increased LPS-induced TNFα production to ~180% of LPS-only levels.
Co-treatment with LY215840 (10 nM, 100 nM, 1 μM) further reduced IL-6 levels to below ~20% of LPS-only levels.
Co-treatment with LY215840 (10 nM, 100 nM, 1 μM) reversed TNFα enhancement, reducing levels to ~80%, ~40%, and ~40% of LPS-only levels, respectively (for 100 nM and 1 μM LY215840).
体内研究
(In Vivo)
Animal Model: Male Sprague-Dawley rats
Dosage: 0.3, 1, 3, 10 mg/kg; single dose
Administration: p.o.
Result: Reduced the synthesis rate of serotonin and increased the social time of rats, but had no effect on motor activity. The motor activity of animals taking the drug for a long time was slightly lower than that of animals taking the drug for a short time.

化学信息

产品应用

1. 该化合物可作为示踪剂。

2. 该化合物可作为 NMR、GC-MS 或 LC-MS 分析中的内标品,用于定量分析。

分子量 333.39
分子式 C19H16D4FNO3
CAS No. 923932-45-0
非标记 CAS 61869-08-7
别名 帕罗西汀-d4; BRL29060-d4

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础